Liquid Biopsy Prevents Inaccurate Her2 Status Determination by in situ Hybridization in a Patient with Invasive Ductal Adenocarcinoma of the Breast: Case Report.

Tzeng, Yen-Dun Tony; Chang, Shih-En; Mei, Rui; Javey, Manana

Tzeng, Yen-Dun Tony; Chang, Shih-En; Mei, Rui; Javey, Manana.

Afiliación

Tzeng YT; Department of Surgery, Division of General Surgery, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan.
Chang SE; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Mei R; CellMax Taiwan Co. Ltd., Taipei, Taiwan.
Javey M; CellMax Inc., Sunnyvale, California, USA.

Case Rep Oncol ; 10(3): 857-862, 2017.

Article en En | MEDLINE | ID: mdl-29071002

Palabras clave

Breast cancer; HER2; Liquid biopsy; Oncolbx; Personalized therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Case Rep Oncol Año: 2017 Tipo del documento: Article País de afiliación: Taiwán